• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

NanoViricides, Inc.

NanoViricides, Inc.

Public
SectorHealthcare
CountryUnited States
Market cap26.02M
NanoViricides, Inc.: A clinical-stage biopharmaceutical company focused on developing nanotechnology-based antiviral therapies that target and dismantle specific viral threats.

Where to buy NanoViricides, Inc.

This company trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare